CYTK insider trading

Latest SEC Form 4 filings by CYTK officers, directors and 10% owners.

Showing the last 30 days. 86 older filings are PRO.See full history →

Open-market buys (0)

No open-market insider buys in recent CYTK filings.

Blum Robert I
President & CEO
$471.1K
Open-market sale · 7,500 sh @ $62.81
Traded 2026-11-02 · Filed 2026-11-02
Malik Fady Ibraham
EVP Research & Development
$224.0K
Open-market sale · 3,500 sh @ $64.01
Traded 2026-10-20 · Filed 2026-10-20
Blum Robert I
President & CEO
$471.6K
Open-market sale · 7,500 sh @ $62.88
Traded 2026-10-12 · Filed 2026-10-13
Malik Fady Ibraham
EVP Research & Development
$214.8K
Open-market sale · 3,500 sh @ $61.38
Traded 2026-10-06 · Filed 2026-10-06

Insider	Transaction	Shares	Price	Value	Traded	Filed
Blum Robert I President & CEO	Open-market sale	7,500	$62.81	$471.1K	2026-11-02	2026-11-02
Malik Fady Ibraham EVP Research & Development	Open-market sale	3,500	$64.01	$224.0K	2026-10-20	2026-10-20
Blum Robert I President & CEO	Open-market sale	7,500	$62.88	$471.6K	2026-10-12	2026-10-13
Malik Fady Ibraham EVP Research & Development	Open-market sale	3,500	$61.38	$214.8K	2026-10-06	2026-10-06

Grants, option exercises, tax withholding and gifts. These usually aren’t a view on the stock.

Blum Robert I
President & CEO
$79.5K
Option exercise · 7,500 sh @ $10.60
Traded 2026-11-02 · Filed 2026-11-02
Malik Fady Ibraham
EVP Research & Development
$27.3K
Option exercise · 3,500 sh @ $7.80
Traded 2026-10-20 · Filed 2026-10-20
Wysenski Nancy
Director
$6.2K
Grant / award · 97 sh @ $63.92
Traded 2026-10-16 · Filed 2026-10-20
Kaye Edward M. MD
Director
$12.5K
Grant / award · 195 sh @ $63.92
Traded 2026-10-16 · Filed 2026-10-20
Harrington Robert Arthur
Director
$12.5K
Grant / award · 195 sh @ $63.92
Traded 2026-10-16 · Filed 2026-10-20
Daly James M
Director
$12.5K
Grant / award · 195 sh @ $63.92
Traded 2026-10-16 · Filed 2026-10-20
WIERENGA WENDELL
Director
$6.2K
Grant / award · 97 sh @ $63.92
Traded 2026-10-16 · Filed 2026-10-20
HENDERSON JOHN T
Director
$22.5K
Grant / award · 352 sh @ $63.92
Traded 2026-10-16 · Filed 2026-10-20
Blum Robert I
President & CEO
$79.5K
Option exercise · 7,500 sh @ $10.60
Traded 2026-10-12 · Filed 2026-10-13
Malik Fady Ibraham
EVP Research & Development
$27.3K
Option exercise · 3,500 sh @ $7.80
Traded 2026-10-06 · Filed 2026-10-06

Insider	Transaction	Shares	Price	Value	Traded	Filed
Blum Robert I President & CEO	Option exercise	7,500	$10.60	$79.5K	2026-11-02	2026-11-02
Malik Fady Ibraham EVP Research & Development	Option exercise	3,500	$7.80	$27.3K	2026-10-20	2026-10-20
Wysenski Nancy Director	Grant / award	97	$63.92	$6.2K	2026-10-16	2026-10-20
Kaye Edward M. MD Director	Grant / award	195	$63.92	$12.5K	2026-10-16	2026-10-20
Harrington Robert Arthur Director	Grant / award	195	$63.92	$12.5K	2026-10-16	2026-10-20
Daly James M Director	Grant / award	195	$63.92	$12.5K	2026-10-16	2026-10-20
WIERENGA WENDELL Director	Grant / award	97	$63.92	$6.2K	2026-10-16	2026-10-20
HENDERSON JOHN T Director	Grant / award	352	$63.92	$22.5K	2026-10-16	2026-10-20
Blum Robert I President & CEO	Option exercise	7,500	$10.60	$79.5K	2026-10-12	2026-10-13
Malik Fady Ibraham EVP Research & Development	Option exercise	3,500	$7.80	$27.3K	2026-10-06	2026-10-06

Source: SEC Form 4 filings. For education and research only. Not financial advice.